Results 1 to 10 of about 49,840 (301)

Case Report: Overcoming calcified nodules by repeated aggressive debulking and stent-free percunatenous coronary intervention using a drug-coated balloon [PDF]

open access: yesFrontiers in Cardiovascular Medicine
BackgroundThe outcomes of percutaneous coronary intervention (PCI) for calcified nodules (CNs) has been unsatisfactory results, even with the use of drug eluting stents.
Atsushi Funatsu   +10 more
doaj   +2 more sources

Case Report: Cytoreductive Surgery and HIPEC Associated With Liver Electrochemotherapy in a Cholangiocarcinoma Patient With Peritoneal Carcinomatosis and Liver Metastasis Case Report

open access: yesFrontiers in Surgery, 2021
Introduction: Cholangiocarcinoma (CCA) is the second most common primary tumor of the liver, and the recurrence after hepatic resection (HR), the only curative therapy, is linked with a worse prognosis.
Mauro Stefano   +11 more
doaj   +1 more source

Complications after advanced ovarian cancer surgery—A population‐based cohort study

open access: yesActa Obstetricia et Gynecologica Scandinavica, 2022
Introduction Surgical complications after primary or interval debulking surgery in advanced ovarian cancer were investigated and associations with patient characteristics and surgical outcomes were explored. Material and methods A population‐based cohort
Charlotte Palmqvist   +5 more
doaj   +1 more source

Unmasking Severe Tricuspid Valve Regurgitation After Percutaneous Debulking of Large Tricuspid Vegetation

open access: yesJACC: Case Reports, 2021
A 27-year-old man admitted with tricuspid valve endocarditis with a large vegetation, persistent bacteremia, and pulmonary and systemic septic embolization was deemed not a suitable surgical candidate. He underwent percutaneous vegetation debulking using
Adrian Mercado-Alamo, MD   +5 more
doaj   +1 more source

Salvage Hepatectomy for Giant GIST Liver Metastases Unresponsive to Systemic Therapy—Case Report

open access: yesLife, 2023
Therapeutic decision-making for advanced GIST liver metastases is challenging due to limited clinical evidence. This case study aims to demonstrate the survival benefit of resection in non-responsive cases.
Alin Kraft   +7 more
doaj   +1 more source

A case of percutaneous tricuspid valve infective endocarditis vegetation debulking using the AngioJet rheolytic catheter system—A novel therapeutic use

open access: yesClinical Case Reports, 2021
In patients with fulminant tricuspid valve infective endocarditis precluded from cardiothoracic intervention based on comorbidities or clinical status, percutaneous vegetation debulking utilizing the AngioJet rheolytic catheter system appears a viable ...
Liam Marsden Back   +3 more
doaj   +1 more source

Edematous Dermal Thickening on Magnetic Resonance Imaging as a Biomarker for Lymphatic Surgical Outcomes

open access: yesMedicina, 2023
Background and Objectives: One of the surgical treatments for breast cancer-related lymphedema (BCRL) is debulking lipectomy. The aim of this study is to investigate whether dermal thickness could be utilized as an objective indicator of post-operative ...
JacqueLyn R. Kinney   +6 more
doaj   +1 more source

The role of quaternary cytoreduction in relapsed ovarian cancer – a systematic review [PDF]

open access: yesArchives of the Balkan Medical Union, 2020
Introduction. Ovarian cancer is characterized by a high capacity of relapse, even in cases in whom cytoreductive surgery with curative intent followed by platinum and taxanes-based chemotherapy were performed.
Nicolae BACALBASA   +6 more
doaj   +1 more source

Predictors of residual disease after debulking surgery in advanced stage ovarian cancer

open access: yesFrontiers in Oncology, 2023
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer survival. The ability to predict likelihood of optimal debulking, which may be partially dependent on tumor biology, could inform clinical decision-making ...
Farnoosh Abbas-Aghababazadeh   +11 more
doaj   +1 more source

Real-World Multicenter Experience in Tumor Debulking Prior to Blinatumomab Administration in Adult Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

open access: yesFrontiers in Oncology, 2022
Blinatumomab is an immunotherapeutic agent with dual specificity for CD3 and CD19 that is approved for the treatment of relapsed/refractory B-cell precursor acute lymphoblastic leukemia (R/R B-ALL).
Massimiliano Bonifacio   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy